Literature DB >> 31177163

Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.

Makoto Sohda1, Tatsuya Miyazaki2, Makoto Sakai2, Yuji Kumakura2, Hiroaki Honjyo2, Keigo Hara2, Naritaka Tanaka2, Takehiko Yokobori2, Ken Shirabe2.   

Abstract

BACKGROUND/AIM: Unresectable oesophageal cancer with surrounding invasion carries a particularly poor prognosis. The chemoradiotherapy treatment for locally-unresectable oesophageal cancer aims to initially control local invasion before proceeding to the next treatment, and is ideally used with curative intent. The aim of this study was to investigate patient treatment course and survival to determine the best treatment and evaluate surgical intervention for these advanced cancers. PATIENTS AND METHODS: A total of 147 patients who were diagnosed with clinical T4b oesophageal cancer were included in this study.
RESULTS: Forty-three patients had undergone curative resection of the tumour and surrounding invasion at midterm evaluation, 104 patients continued with definitive chemoradiotherapy, and salvage surgery was performed in 21 patients. Multivariate analysis of disease-specific survival showed that response at the midterm evaluation and surgical intervention (conversion surgery + salvage surgery) were significant prognostic factors.
CONCLUSION: Surgical intervention was an independent prognostic factor, and operation should be performed in eligible patients after considering the risks and proper timing. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Advanced oesophageal cancer; response; surgery

Mesh:

Year:  2019        PMID: 31177163     DOI: 10.21873/anticanres.13454

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

1.  Efficacy of thoracotomy and thoracoscopic-assisted esophageal surgery in conversion and salvage surgeries: a retrospective study.

Authors:  Isamu Hoshino; Hisashi Gunji; Naoki Kuwayama; Takeshi Kurosaki; Toru Tonooka; Hiroaki Soda; Nobuhiro Takiguchi; Yoshihiro Nabeya; Wataru Takayama
Journal:  World J Surg Oncol       Date:  2022-05-23       Impact factor: 3.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.